These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5392912)

  • 1. A comparison of 4-amino-4-deoxy-N10-methylpteroic acid and methotrexate transport by mouse leukemia cells.
    Kessel D
    Mol Pharmacol; 1969 Jan; 5(1):21-5. PubMed ID: 5392912
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
    [No Abstract]   [Full Text] [Related]  

  • 3. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 4. Characteristics of folic acid transport in the L1210 leukemia cell.
    Lichtenstein NS; Oliverio VT; Goldman ID
    Biochim Biophys Acta; 1969; 193(2):456-67. PubMed ID: 5389249
    [No Abstract]   [Full Text] [Related]  

  • 5. A model system for the study of heteroexchange diffusion: methotrexate-folate interactions in L1210 leukemia and Ehrlich ascites tumor cells.
    Goldman ID
    Biochim Biophys Acta; 1971 Jun; 233(3):624-34. PubMed ID: 5113921
    [No Abstract]   [Full Text] [Related]  

  • 6. Alterations in the kinetics of methotrexate transport during growth of L1210 murine leukemia cells in culture.
    Chello PL; Sirotnak FM; Dorick DM
    Mol Pharmacol; 1980 Sep; 18(2):274-80. PubMed ID: 7421795
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells.
    Henderson GB
    Prog Clin Biol Res; 1983; 132B():415-23. PubMed ID: 6634763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 11. On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia.
    Sirotnak FM; Kurita S; Hutchison DJ
    Cancer Res; 1968 Jan; 28(1):75-80. PubMed ID: 5635374
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversibility of high-affinity binding of methotrexate in L1210 murine leukemia cells.
    Cohen M; Bender RA; Donehower R; Myers CE; Chabner BA
    Cancer Res; 1978 Sep; 38(9):2866-70. PubMed ID: 679194
    [No Abstract]   [Full Text] [Related]  

  • 15. An apparent relationship between responsiveness to folinic acid protection from methotrexate cytotoxicity and uptake of 5-methyltetrahydrofolate in a series of murine cell lines.
    Goldie JH; Hill BT
    Cancer Biochem Biophys; 1979; 3(3):111-5. PubMed ID: 317897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells.
    Henderson GB; Russell A; Whiteley JM
    Arch Biochem Biophys; 1980 Jun; 202(1):29-34. PubMed ID: 6772112
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate analogues. 8. Synthesis and biological evaluation of bisamide derivatives as potential prodrugs.
    Rosowsky A; Ensminger WD; Lazarus H; Yu CS
    J Med Chem; 1977 Jul; 20(7):925-30. PubMed ID: 406398
    [No Abstract]   [Full Text] [Related]  

  • 18. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 19. S-phase cells of rapidly growing and resting populations. Differences in response to methotrexate.
    Hryniuk WM; Fischer GA; Bertino JR
    Mol Pharmacol; 1969 Nov; 5(6):557-64. PubMed ID: 5392913
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.
    Scanlon KJ; Kashani-Sabet M; Cashmore AR; Pallai M; Moroson BA; Saketos M
    Cancer Chemother Pharmacol; 1987; 19(1):25-9. PubMed ID: 3815722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.